-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/measuring-blood-pressure_executive.pdf
January 01, 2012 - disease,6 and is
an important modifiable risk factor for coronary artery
disease, stroke, peripheral vascular … Age-specific
relevance of usual blood pressure to vascular mortality.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_executive.pdf
May 01, 2010 - divided into adults and pediatric
populations), obstetrics, aortic aneurysm, prostate
surgery, other vascular … clotting
disorders (4 percent), secondary clotting disorders
(4 percent), and aortic aneurysm and other vascular
-
www.ahrq.gov/sites/default/files/2025-02/platt-report.pdf
January 01, 2025 - Improvement Project (SCIP), which include CABG,
other cardiac surgery, hip arthroplasty, knee arthroplasty, vascular … hospitals with higher rates of surgical site infection following vascular surgery. Med Care. 2014.
-
www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/breast-cancer-medications-for-risk-reduction
September 03, 2019 - Vascular events in the Multiple Outcomes of Raloxifene Evaluation (MORE) trial: incidence, patient characteristics … -9)
ND
Nonvertebral
3 (0.2-5)
ND
ND
Harms: Events Increased (95% CI) a
Vascular
-
hcup-us.ahrq.gov/reports/statbriefs/sb232-Hepatitis-C-Hospital-Stays-Trends.pdf
June 19, 2017 - Diabetes with chronic complications 3.6 7.8 8.2 6.3 5.1
Peripheral vascular … 12.7
Weight loss 8.3 12.5 5.7
Diabetes with chronic complications 8.5 5.1 7.4
Peripheral vascular
-
hcup-us.ahrq.gov/reports/statbriefs/sb222-Preeclampsia-Eclampsia-Delivery-Trends.pdf
December 01, 2016 - ill-defined, cerebrovascular disease
437 Other and ill-defined cerebrovascular disease
997.2 Peripheral vascular … complications
999.2 Other vascular complications
518.4 Acute edema of lung, unspecified
Pulmonary
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/pwd-care-interventions-protocol.pdf
February 22, 2019 - disease is the most common form of progressive dementia and—
grouped with Lewy body, frontotemporal, vascular … ADRD – Alzheimer’s disease related dementias (i.e., frontotemporal dementia, Lewy
body dementia, and vascular
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/MLeu_yFpPwzcZwKG6fw5ZY
April 26, 2022 - Use of aspirin to
reduce risk of initial vascular events in patients at
moderate risk of cardiovascular … for patients with coronary and other atherosclerotic
vascular disease: 2011 update: a guideline from
-
hcup-us.ahrq.gov/reports/natstats/his95/table1.pdf
February 11, 2011 - Cataract [86.] 8,604 0.02 $4,190 $2,879 $3,491 $5,078 1.5 0.0 35.5 73
6.7.2 Retinal detachments, defects, vascular … arteries of
extremities 72,943 0.21 $19,069 $8,858 $14,528 $23,258 6.6 2.2 56.8 69
7.4.1.2 Peripheral vascular
-
www.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-PUF-Summary-Statistics-Medicaid-Inpatient-Weighted.pdf
September 26, 2023 - included Independent Diagnostic Testing
Facilities (IDTF)
1,871 0.02 7,241,924 83.45
76: Peripheral vascular … Attending Provider Specialty
AT_SPCLTY Frequency Percent
Cumulative
Frequency
Cumulative
Percent
77: Vascular
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction
September 03, 2019 - Vascular events in the Multiple Outcomes of Raloxifene Evaluation (MORE) trial: incidence, patient characteristics … -9)
ND
Nonvertebral
3 (0.2-5)
ND
ND
Harms: Events Increased (95% CI) a
Vascular
-
hcup-us.ahrq.gov/reports/statbriefs/sb232-Hepatitis-C-Hospital-Stays-Trends.jsp
December 01, 2017 - 7.8
4.9
Diabetes with chronic complications
3.6
7.8
8.2
6.3
5.1
Peripheral vascular … loss
8.3
12.5
5.7
Diabetes with chronic complications
8.5
5.1
7.4
Peripheral vascular
-
hcup-us.ahrq.gov/reports/statbriefs/sb222-Preeclampsia-Eclampsia-Delivery-Trends.jsp
April 01, 2017 - cerebrovascular disease
437
Other and ill-defined cerebrovascular disease
997.2
Peripheral vascular … complications
999.2
Other vascular complications
518.4
Acute edema of lung, unspecified
-
pso.ahrq.gov/pso/listed/printable-list
December 22, 2010 - Contract Requirement: Next attestation period is 05/10/2025
through 05/09/2027
Society for Vascular … Patient Safety Organization, LLC PSO Number: P0106 Components of Parent Org(s):
Society for Vascular
-
www.ahrq.gov/patient-safety/settings/long-term-care/resource/ontime/prevhosp/ereportguide.html
September 01, 2017 - urinary tract infection, sepsis or fever or infection, dehydration, circulatory problems [includes vascular … urinary tract infection, sepsis or fever or infection, dehydration, circulatory problems [includes vascular
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/nicu_toolkit/nicupacket-apb.pdf
June 02, 2025 - – Stages 1-5: degree of vasculopathy at the vascular-avascular transition (Stage 5 is most
severe
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-228-fullreport.pdf
February 01, 2018 - The treatment of septic shock in children is intended to optimize perfusion of critical vascular
beds … resuscitation and
appropriate antibiotics), as well as suboptimal resuscitation, contribute to peripheral vascular
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1506.pdf
October 01, 2015 - proangiogenic growth factor receptors purportedly involved in the
pathogenesis of IPF, including vascular … intracellular signaling by inhibiting the proliferative growth factor receptor kinase
activity of vascular … solution also contains a low concentration of potassium ions to reduce free-radical generation
and avoid vascular
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes_hi_impact.pdf
March 01, 2012 - over long-term effects of
extended-release exenatide, “particularly those associated with cardio-vascular
-
www.ahrq.gov/sites/default/files/2025-03/smith-werner-carayon-report.pdf
January 01, 2025 - risk factors for diabetes and its complications conditions only; Class 3:
patients with non-cardiac vascular … conditions but without advanced cardiac
disease conditions, with or without risk factors or non-cardiac vascular … from discharge to 7-day revisit for
Class 3 patients (i.e., patients with diabetes and non-cardiac vascular